[1] Bennani-Baiti, B., Dietzel, M. and Baltzer, P.A. (2016) MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer. PLoS ONE, 11, 7.
https://doi.org/10.1371/journal.pone.0158573
[2] Pike, M.C. and Pearce, C.L. (2013) Mammographic Density, MRI Background Parenchymal Enhancement and Breast Cancer Risk. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 24, 37-41.
[3] Zeppa, R. (1969) Vascular Response of the Breast to Estrogen. The Journal of Clinical Endocrinology and Metabolism, 29, 695-700.
https://doi.org/10.1210/jcem-29-5-695
[4] Hambly, N.M., Liberman, L., Dershaw, D.D., Brennan, S. and Morris, E.A. (2011) Background Parenchymal Enhancement on Baseline Screening Breast MRI: Impact on Biopsy Rate and Short-Interval Follow-Up. AJR American Journal of Roentgenology, 196, 218-224.
https://doi.org/10.2214/AJR.10.4550
[5] King, V., Brooks, J.D., Bernstein, J.L., Reiner, A.S., Pike, M.C. and Morris, E.A. (2011) Background Parenchymal Enhancement at Breast MR Imaging and Breast Cancer Risk. Radiology, 260, 50-60.
https://doi.org/10.1148/radiol.11102156
[6] Muller-Schimpfle, M., Ohmenhauser, K., Stoll, P., Dietz, K. and Claussen, C.D. (1997) Menstrual Cycle and Age: Influence on Parenchymal Contrast Medium Enhancement in MR Imaging of the Breast. Radiology, 203, 145-149.
https://doi.org/10.1148/radiology.203.1.9122383
[7] Morris, E.A., Comstock, C.E. and Lee, C.H. (2013) ACR BI-RADS® Magnetic Resonance Imaging. In: ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System, Reston, VA, American College of Radiology.
[8] Menezes, G.L., Knuttel, F.M., Stehouwer, B.L., Pijnappel, R.M. and Van den Bosch, M.A. (2014) Magnetic Resonance Imaging in Breast Cancer: A Literature Review and Future Perspectives. World Journal of Clinical Oncology, 5, 61-70.
https://doi.org/10.5306/wjco.v5.i2.61
[9] Kuhl, C.K. (2007) Current Status of Breast MR Imaging. Part 2. Clinical Applications. Radiology, 244, 672-691.
https://doi.org/10.1148/radiol.2443051661
[10] Orel, S.G. and Schnall, M.D. (2001) MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast Cancer. Radiology, 220, 13-30.
https://doi.org/10.1148/radiology.220.1.r01jl3113
[11] Kawamura, A., Satake, H., Ishigaki, S., Ikeda, M., Kimura, R., Shimamoto, K. and Shinji, N. (2015) Prediction of Background Parenchymal Enhancement on Breast MRI Using Mammography, Ultrasonography, and Diffusion-Weighted Imaging. Nagoya Journal of Medical Science, 77, 425-437.
[12] Kuhl, C. (2007) The Current Status of Breast MR Imaging. Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice. Radiology, 244, 356-378.
https://doi.org/10.1148/radiol.2442051620
[13] De Martini, W.B., Liu, F., Peacock, S., Eby, P.R., Gutierrez, R.L. and Lehman, C.D. (2012) Background Parenchymal Enhancement on Breast MRI: Impact on Diagnostic Performance. AJR American Journal of Roentgenology, 198, 373-380.
https://doi.org/10.2214/AJR.10.6272
[14] Telegrafo, M., Rella, L., Stabile Ianora, A.A., Angelelli, G. and Moschetta, M. (2016) Breast MRI Background Parenchymal Enhancement (BPE) Correlates with the Risk of Breast Cancer. Magnetic Resonance Imaging, 34, 173-176.
https://doi.org/10.1016/j.mri.2015.10.014
[15] Telegrafo, M., Rella, L., Stabile Ianora, A.A., Angelelli, G. and Moschetta, M. (2016) Effect of Background Parenchymal Enhancement on Breast Cancer Detection with Magnetic Resonance Imaging. Diagnostic and Interventional Imaging, 97, 315-320.
https://doi.org/10.1016/j.diii.2015.12.006
[16] Giess, C.S., Yeh, E.D., Raza, S. and Birdwell, R.L. (2014) Background Parenchymal Enhancement at Breast MR Imaging: Normal Patterns, Diagnostic Challenges, and Potential for False-Positive and False-Negative Interpretation. Radiographics: A Review Publication of the Radiological Society of North America, 34, 234-247.
https://doi.org/10.1148/rg.341135034
[17] Vogel, P.M., Georgiade, N.G., Fetter, B.F., Vogel, F.S. and McCarty, K.S. (1981) The Correlation of Histologic Changes in the Human Breast with the Menstrual Cycle. The American Journal of Pathology, 104, 23-34.